NovaBridge Biosciences (NBP) stock
NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.83−0.05 (-5.66%)
Close on Nov 20, 2026Market cap $95.77MP/E –Yield –
NovaBridge Biosciences gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2022 it was -CN¥248.80M, down 698.2% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -CN¥248.80M | -698.2% |
| FY2021 | Dec 31, 2021 | CN¥41.59M | -97.3% |
| FY2020 | Dec 31, 2020 | CN¥1.54B | +5042.2% |
| FY2019 | Dec 31, 2019 | CN¥30.00M | – |
See a number that looks wrong?